Lymphocyte-based ratios for predicting respiratory failure in Guillain-Barré syndrome

[1]  E. Can,et al.  The value of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) parameters in analysis with fetal malnutrition neonates , 2019, Journal of perinatal medicine.

[2]  M. Çalık,et al.  Effect of serum inflammatory markers on the prognosis of adult and pediatric patients with Guillain–Barré syndrome , 2018, Neuropsychiatric disease and treatment.

[3]  A. Dai,et al.  Association of Neutrophil/Lymphocyte Ratio With Intravenous Immunoglobulin Treatment in Children With Guillain-Barré Syndrome , 2018, Journal of child neurology.

[4]  Jia Li,et al.  The clinical significance of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in Guillain–Barré syndrome , 2018, The International journal of neuroscience.

[5]  C. You,et al.  Clinical Value of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratio After Aneurysmal Subarachnoid Hemorrhage , 2017, Neurocritical Care.

[6]  Liang Chen,et al.  Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil , 2016, Medicine.

[7]  Dazhi Xu,et al.  Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I–II gastric cancer , 2016, Chinese journal of cancer.

[8]  S. Kutluhan,et al.  The clinical significance of the neutrophil-to-lymphocyte ratio in multiple sclerosis , 2015, The International journal of neuroscience.

[9]  C. Ozturk,et al.  The platelet-lymphocyte ratio: A simple, inexpensive and rapid prognostic marker for cardiovascular events , 2015, Platelets.

[10]  D. Hermann,et al.  Role of Neutrophils in Exacerbation of Brain Injury After Focal Cerebral Ischemia in Hyperlipidemic Mice , 2015, Stroke.

[11]  F. Sharp,et al.  Targeting Neutrophils in Ischemic Stroke: Translational Insights from Experimental Studies , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  H. Özdemir,et al.  The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson’s disease , 2015, Neurological Sciences.

[13]  B. Jacobs,et al.  Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis , 2014, Nature Reviews Neurology.

[14]  Judith Drenthen,et al.  Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. , 2014, Brain : a journal of neurology.

[15]  Z. Akpınar,et al.  Neutrophil lymphocyte ratio as a predictor of stroke. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[16]  Sharon Chiang,et al.  The role of chemokines in guillain–barré syndrome , 2013, Muscle & nerve.

[17]  Z. A. Oztürk,et al.  The Evaluation of Neutrophil-Lymphocyte Ratio in Alzheimer’s Disease , 2012, Dementia and Geriatric Cognitive Disorders.

[18]  D. Talwar,et al.  A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. , 2011, European journal of cancer.

[19]  Jie Zhu,et al.  The role of cytokines in Guillain–Barré syndrome , 2011, Journal of Neurology.

[20]  A. Pithadia,et al.  Guillain-Barré syndrome (GBS) , 2010, Pharmacological reports : PR.

[21]  D. McMillan.  Systemic inflammation, nutritional status and survival in patients with cancer , 2009, Current opinion in clinical nutrition and metabolic care.

[22]  H. Schluesener,et al.  Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline , 2008, Journal of cellular and molecular medicine.

[23]  D. Cornblath,et al.  Assessment of current diagnostic criteria for Guillain‐Barré syndrome , 1990, Annals of neurology.

[24]  R. Hughes,et al.  CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY , 1978, The Lancet.